The launch of the Sustainable Development Goals (SDGs), the successor to the MDGs, last week in New York, marks yet another milestone in committing global leadership to the development agenda. I attended and participated in various events linked to the Equitable Access Initiative(EAI), with Global Fund and EAI partners, UNFPA, Gates Foundation, UN Foundation, Civil society, and the private sector. Quantity vs quality There are a few things to note. Goals grew more ambitious while...read full post
RethinkHIV researcher Dr. Anna Vassall of London School of Hygiene & Tropical Medicine is a signatory of a full-page advertisement in the New York Times with 266 other economists calling for greater health investment. The declaration states, “Our generation has a historic opportunity to achieve a ‘grand convergence’ in global health, reducing preventable maternal, child and infectious disease deaths to universally low levels by 2035.” Ahead of the adoption of the Global Goals at the United Nations in New York,...read full post
RethinkHIV is a consortium of senior researchers from London School of Hygiene & Tropical Medicine, Imperial College London, Harvard School of Public Health, Centre for the Study of African Economies and Blavatnik School of Government at Oxford University.
The consortium will evaluate new evidence related to the costs, benefits, effects, fiscal implications, and developmental impacts of HIV interventions in sub-Saharan Africa, in order to maximise contributions to the fight against HIV there.
The aim of RethinkHIV is to find ways of creating, optimising, and sustaining fiscal space for domestic HIV investment, as well as exploring long-term, sustainable national and international financing mechanisms. RethinkHIV is funded by RUSH Foundation.